Review Article

Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies

Table 1

Studies evaluating IL-33 in intestinal samples from inflammatory bowel disease patients are listed chronologically with data regarding the sample collection site and the control group.

StudiesIBD patients in remissionIBD patients in flareControls
Noninvolved area Involved area
(healed)
Noninvolved areaInvolved area

Kobori et al., (2010) [15]Cancer patients
Pastorelli et al., (2010) [16]Cancer screening
Diverticulitis
Infectious colitis
Seidelin et al., (2010) [17]Cancer screening
Beltrán et al., (2010) [18]Non-IBD
Sponheim et al., (2010) [19]Irritable bowel syndrome
Sedhom et al., (2012) [20]Cancer patients
Cancer screening
Wakahara et al., (2012) [21]Non-IBD